Mary Jo Lechowicz, MD

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (210 ratings)

Role

Hematology Oncology
Specialty

Lymphoma
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2003

Request Appointment

Background

Mary Jo Lechowicz, MD, joined Emory from the Sidney Kimmel Cancer Center at Johns Hopkins University where she completed a post-doctoral fellowship in oncology. Dr. Lechowicz is board certified in medical oncology. Dr. Lechowicz's research interests are in hematologic malignancies. She has been a principal investigator and co-principal investigator on a number of national and international clinical trials involving the treatment of patients with virally related cancers, particularly T-cell non-Hodgkin lymphoma and non-hodgen's lymphoma in particular.

Dr. Lechowicz is currently active in the American Society of Clinical Oncology, the Discovery and Developmental Therapeutics Research Program, the American Society of Hematology, the American Medical Association, the American Association of Medical Colleges and the American Association of Cancer Research. She is a member of the Discovery and Developmental Therapeutics Research Program at Winship.

Dr. Lechowicz earned her medical degree from SUNY-Syracuse in Syracuse, New York. She completed her internship and residency at Columbia Presbyterian Medical Center in New York, New York where she was also a Chief Resident. She then completed a fellowship at the Sidney Kimmel Cancer Center at Johns Hopkins Hospital in Baltimore, Maryland.

Titles & Roles

Professor and Vice Chair for Education, Department of Hematology and Medical Oncology

Emory University School of Medicine
Margaret H. Rollins Chair in Cancer

Winship Cancer Institute of Emory University

Education & Training

Education

Fellowship, Medical Oncology, 2003
John Hopkins Bayview Medical Ctr
Residency, Internal Medicine, 1999
Columbia Presbyterian Med Ctr
Internship, Internal Medicine, 1997
Columbia Presbyterian Med Ctr
Medical Education, , 1996
SUNY - Syracuse

Board Certifications

Medical Oncology
American Board of Internal Medicine, 2004

Title/Journal	Authors	Publication Date
Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis. International journal of hematology	MJ Lechowicz, C Smith, R Ristuccia, K Dwyer	27/03/2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease. Haematologica	MS Bustamante, SK Pierson, Y Ren, A Bagg, JD Brandstadter, G Srkalovic, N Mango, D Alapat, MJ Lechowicz, H Li, F Van Rhee, MS Lim, DC Fajgenbaum	11/01/2024
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study. Haematologica	SP Iyer, A Huen, WZ Ai, D Jagadeesh, MJ Lechowicz, C Okada, TA Feldman, P Ghione, JP Alderuccio, R Champion, SH Kim, A Mohrbacher, KV Routhu, P Barde, AM Nair, BM Haverkos	01/01/2024
Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature. CNS oncology	JD Preston, CS Jansen, S Kosaraju, T Niyogusaba, TZ Zhuang, SW Iwamoto, SK Hutto, MJ Lechowicz, PB Allen	01/12/2023
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes. Blood advances	SK Pierson, MS Lim, G Srkalovic, JD Brandstadter, M Sarmiento Bustamante, S Shyamsundar, N Mango, C Lavery, B Austin, D Alapat, MJ Lechowicz, A Bagg, H Li, C Casper, F van Rhee, DC Fajgenbaum	14/11/2023
Ongoing symptoms following complete surgical excision in unicentric Castleman disease. American journal of hematology	M Sarmiento Bustamante, S Shyamsundar, FR Coren, A Bagg, G Srkalovic, D Alapat, F van Rhee, MS Lim, MJ Lechowicz, JD Brandstadter, SK Pierson, DC Fajgenbaum	01/11/2023
Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study. Clinical lymphoma, myeloma & leukemia	TZ Zhuang, A McCook-Veal, J Switchenko, T Niyogusaba, ES Tarabadkar, K Baird, C O'Leary, D Paulino, MJ Lechowicz, PB Allen	01/09/2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. British journal of haematology	R Stuver, SM Horwitz, RH Advani, JM Vose, HJ Lee, N Mehta-Shah, JM Zain, B Haverkos, MJ Lechowicz, AJ Moskowitz, LQ Pham, E Leyden, SM Ansell, MA Lunning	01/08/2023
Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia. Leukemia & lymphoma	PB Allen, S Goyal, J Switchenko, E Tarabadkar, S Pouch, P Parikh, A Palmer, D Martini, E Kim, MJ Lechowicz	01/03/2023
Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study. Cancer	PB Allen, AA McCook-Veal, JM Switchenko, DM Paulino, T Niyogusaba, KM Baird, ES Tarabadkar, MJ Lechowicz	15/02/2023
Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies. Cancer research communications	A Chang, A Akhtar, L Lai, VM Orellana-Noia, SL Linderman, AA McCook-Veal, JM Switchenko, M Saini, RM Valanparambil, KA Blum, PB Allen, MJ Lechowicz, JT Romancik, A Ayers, A Leal, CB O'Leary, MC Churnetski, K Baird, M Kives, J Wrammert, AK Nooka, JL Koff, MV Dhodapkar, MS Suthar, JB Cohen, R Ahmed	01/12/2022
Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary Syndrome. JAMA dermatology	PB Allen, S Goyal, T Niyogusaba, C O'Leary, A Ayers, ES Tarabadkar, MK Khan, MJ Lechowicz	01/11/2022
CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia. Clinical lymphoma, myeloma & leukemia	A Chang, L Lai, A Akhtar, S Linderman, V Orellana-Noia, M Saini, R Valanparambil, K Blum, P Allen, M Lechowicz, J Romancik, A Ayers, C O'Leary, M Churnetski, M Kives, A Nooka, J Koff, M Dhodapkar, M Suthar, J Cohen, R Ahmed	27/09/2022
African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center. Leukemia & lymphoma	DJ Martini, S Goyal, JM Switchenko, MJ Lechowicz, PB Allen	01/09/2022
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood	EA Olsen, S Whittaker, R Willemze, L Pinter-Brown, F Foss, L Geskin, L Schwartz, S Horwitz, J Guitart, J Zic, YH Kim, GS Wood, M Duvic, W Ai, M Girardi, A Gru, E Guenova, E Hodak, R Hoppe, W Kempf, E Kim, MJ Lechowicz, P Ortiz-Romero, E Papadavid, P Quaglino, M Pittelkow, HM Prince, JA Sanches, M Sugaya, M Vermeer, J Zain, R Knobler, R Stadler, M Bagot, J Scarisbrick	04/08/2022
The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry. British journal of haematology	DC Fajgenbaum, SK Pierson, K Kanhai, A Bagg, D Alapat, MS Lim, MJ Lechowicz, G Srkalovic, TS Uldrick, F van Rhee	01/07/2022
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma. Annals of hematology	M Krishnan, RG Bociek, M Fanale, SP Iyer, MJ Lechowicz, PJ Bierman, JO Armitage, M Lunning, A Kallam, JM Vose	01/02/2022
Racial differences in clinical presentation and outcomes in mycosis fungoides and Sézary syndrome in the United States: a large singe center retrospective analysis. European journal of cancer (Oxford, England : 1990)	PB Allen, S Goyal, C O'Leary, A Ayers, T Niyogusaba, MK Khan, MJ Lechowicz	01/10/2021
T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma. JAMA dermatology	JA Marks, JM Switchenko, DJ Martini, ES Tarabadkar, MK Khan, MJ Lechowicz, PB Allen	01/08/2021
Nivolumab-associated cutaneous T-cell lymphoma. JAAD case reports	JA Marks, DC Parker, LC Garrot, MJ Lechowicz	01/03/2021
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood advances	F van Rhee, E Oksenhendler, G Srkalovic, P Voorhees, M Lim, A Dispenzieri, M Ide, S Parente, S Schey, M Streetly, R Wong, D Wu, I Maillard, J Brandstadter, N Munshi, W Bowne, KS Elenitoba-Johnson, A Fössa, MJ Lechowicz, S Chandrakasan, SK Pierson, A Greenway, S Nasta, K Yoshizaki, R Kurzrock, TS Uldrick, C Casper, A Chadburn, DC Fajgenbaum	08/12/2020
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. American journal of hematology	DC Fajgenbaum, D Wu, A Goodman, R Wong, A Chadburn, S Nasta, G Srkalovic, S Mukherjee, H Leitch, R Jayanthan, S Ferrero, Y Sato, S Schey, A Dispenzieri, E Oksenhendler, PL Zinzani, MJ Lechowicz, C Hoffmann, N Pemmaraju, A Bagg, A Fossa, MS Lim, F van Rhee	01/12/2020
Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy. Clinical lymphoma, myeloma & leukemia	MR Kudelka, JM Switchenko, MJ Lechowicz, N Esiashvili, CR Flowers, MK Khan, PB Allen	01/11/2020
Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL). Leukemia & lymphoma	PB Allen, J Switchenko, A Ayers, E Kim, MJ Lechowicz	01/11/2020
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma. Cancers	A Huen, BM Haverkos, J Zain, R Radhakrishnan, MJ Lechowicz, S Devata, NJ Korman, L Pinter-Brown, Y Oki, PJ Barde, A Nair, KV Routhu, S Viswanadha, S Vakkalanka, SP Iyer	15/08/2020
Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab. JAAD case reports	SA Westergaard, MJ Lechowicz, M Harrington, J Elsey, JL Arbiser, MK Khan	01/08/2020
Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia. Cancer	L Clough, AR Bayakly, KC Ward, MK Khan, SC Chen, MJ Lechowicz, CR Flowers, PB Allen, JM Switchenko	15/04/2020
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study. Cancer	JB Cohen, L Wei, KJ Maddocks, B Christian, LT Heffner, AA Langston, MJ Lechowicz, P Porcu, CR Flowers, SM Devine, KA Blum	15/03/2020
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry. Acta haematologica	F Lansigan, SM Horwitz, LC Pinter-Brown, ST Rosen, B Pro, ED Hsi, M Federico, C Gisselbrecht, M Schwartz, LA Bellm, M Acosta, AR Shustov, RH Advani, T Feldman, MJ Lechowicz, SM Smith, A Tulpule, MD Craig, JP Greer, BS Kahl, JW Leach, N Morganstein, C Casulo, SI Park, FM Foss	01/01/2020
Management of NK/T-Cell Lymphoma, Nasal Type. Journal of oncology practice	PB Allen, MJ Lechowicz	01/10/2019
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study. Cancer	SI Park, SM Horwitz, FM Foss, LC Pinter-Brown, KR Carson, ST Rosen, B Pro, ED Hsi, M Federico, C Gisselbrecht, M Schwartz, LA Bellm, M Acosta, RH Advani, T Feldman, MJ Lechowicz, SM Smith, F Lansigan, A Tulpule, MD Craig, JP Greer, BS Kahl, JW Leach, N Morganstein, C Casulo, AR Shustov	01/05/2019
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. The Lancet. Haematology	K Dunleavy, MA Fanale, JS Abramson, A Noy, PF Caimi, S Pittaluga, S Parekh, A Lacasce, JW Hayslip, D Jagadeesh, S Nagpal, MJ Lechowicz, R Gaur, A Lucas, C Melani, M Roschewski, SM Steinberg, ES Jaffe, B Kahl, JW Friedberg, RF Little, NL Bartlett, WH Wilson	01/12/2018
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood	F van Rhee, P Voorhees, A Dispenzieri, A Fosså, G Srkalovic, M Ide, N Munshi, S Schey, M Streetly, SK Pierson, HL Partridge, S Mukherjee, D Shilling, K Stone, A Greenway, J Ruth, MJ Lechowicz, S Chandrakasan, R Jayanthan, ES Jaffe, H Leitch, N Pemmaraju, A Chadburn, MS Lim, KS Elenitoba-Johnson, V Krymskaya, A Goodman, C Hoffmann, PL Zinzani, S Ferrero, L Terriou, Y Sato, D Simpson, R Wong, JF Rossi, S Nasta, K Yoshizaki, R Kurzrock, TS Uldrick, C Casper, E Oksenhendler, DC Fajgenbaum	15/11/2018
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network. British journal of haematology	M Federico, M Bellei, L Marcheselli, M Schwartz, M Manni, V Tarantino, S Pileri, YH Ko, ME Cabrera, S Horwitz, WS Kim, A Shustov, FM Foss, A Nagler, K Carson, LC Pinter-Brown, S Montoto, M Spina, TA Feldman, MJ Lechowicz, SM Smith, F Lansigan, R Gabus, JM Vose, RH Advani	01/06/2018
Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas. Cancer management and research	PB Allen, MJ Lechowicz	01/01/2018
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States. Cancer	KR Carson, SM Horwitz, LC Pinter-Brown, ST Rosen, B Pro, ED Hsi, M Federico, C Gisselbrecht, M Schwartz, LA Bellm, MA Acosta, AR Shustov, RH Advani, TA Feldman, MJ Lechowicz, SM Smith, F Lansigan, A Tulpule, MD Craig, JP Greer, BS Kahl, JW Leach, N Morganstein, C Casulo, SI Park, FM Foss	01/04/2017
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States. Clinical lymphoma, myeloma & leukemia	ED Hsi, SM Horwitz, KR Carson, LC Pinter-Brown, ST Rosen, B Pro, M Federico, C Gisselbrecht, M Schwartz, LA Bellm, M Acosta, AM Collie, AM Gruver, BJ Grzywacz, S Turakhia, AR Shustov, RH Advani, T Feldman, MJ Lechowicz, SM Smith, F Lansigan, A Tulpule, MD Craig, JP Greer, BS Kahl, JW Leach, N Morganstein, C Casulo, SI Park, FM Foss	01/04/2017
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood	DC Fajgenbaum, TS Uldrick, A Bagg, D Frank, D Wu, G Srkalovic, D Simpson, AY Liu, D Menke, S Chandrakasan, MJ Lechowicz, RS Wong, S Pierson, M Paessler, JF Rossi, M Ide, J Ruth, M Croglio, A Suarez, V Krymskaya, A Chadburn, G Colleoni, S Nasta, R Jayanthan, CS Nabel, C Casper, A Dispenzieri, A Fosså, D Kelleher, R Kurzrock, P Voorhees, A Dogan, K Yoshizaki, F van Rhee, E Oksenhendler, ES Jaffe, KS Elenitoba-Johnson, MS Lim	23/03/2017
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone marrow transplantation	Z DeFilipp, CB Rosand, DA Goldstein, VA Master, BC Carthon, WB Harris, O Kucuk, Z Al-Kadhimi, JB Cohen, CR Flowers, MJ Lechowicz, AK Nooka, JL Kaufman, AA Langston, Z Chen, J Arora, EK Waller	01/01/2017
T-cell Lymphoma Epidemiology: the Known and Unknown. Current hematologic malignancy reports	A Phan, R Veldman, MJ Lechowicz	01/12/2016
Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome. Leukemia & lymphoma	HH Danish, S Liu, J Jhaveri, CR Flowers, MJ Lechowicz, N Esiashvili, MK Khan	01/12/2016
Human immunodeficiency virus lymphomas in the era of antiretrovirals: Is it finally time to change the discussion? Cancer	CJ Gunthel, MJ Lechowicz	01/09/2016
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	OW Press, H Li, H Schöder, DJ Straus, CH Moskowitz, M LeBlanc, LM Rimsza, NL Bartlett, AM Evens, ES Mittra, AS LaCasce, JW Sweetenham, PM Barr, MA Fanale, MV Knopp, A Noy, ED Hsi, JR Cook, MJ Lechowicz, RD Gascoyne, JP Leonard, BS Kahl, BD Cheson, RI Fisher, JW Friedberg	10/06/2016
CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation. Dermatology and therapy	HH Danish, TR Heumann, KT Bradley, J Switchenko, N Esiashvili, MJ Lechowicz, CR Flowers, MK Khan	01/06/2016
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial. British journal of haematology	RH Advani, SM Ansell, MJ Lechowicz, AW Beaven, F Loberiza, KR Carson, AM Evens, F Foss, S Horwitz, B Pro, LC Pinter-Brown, SM Smith, AR Shustov, KJ Savage, JM Vose	01/02/2016
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma. British journal of haematology	JB Cohen, JM Switchenko, JL Koff, R Sinha, JL Kaufman, HJ Khoury, N Bumpers, A Colbert, A Hutchison-Rzepka, LJ Nastoupil, LT Heffner, AA Langston, MJ Lechowicz, S Lonial, CR Flowers	01/11/2015
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial. Transfusion	N Jagirdar, RD Harvey, A Nooka, C Flowers, J Kaufman, S Lonial, MJ Lechowicz, A Langston, C Lipscomb, C Gaylor, EK Waller	01/10/2015
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma. Clinical lymphoma, myeloma & leukemia	JB Cohen, S Bucur, EF Winton, R Sinha, LT Heffner, N King, S Lonial, AA Langston, EK Waller, A Hutchison-Rzepka, A Colbert, MJ Lechowicz, CR Flowers	01/09/2015
Clinical development of siltuximab. Current oncology reports	CC Davis, KS Shah, MJ Lechowicz	01/07/2015
Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique. International journal of radiation oncology, biology, physics	TR Heumann, N Esiashvili, S Parker, JM Switchenko, A Dhabbaan, M Goodman, MJ Lechowicz, CR Flowers, MK Khan	01/05/2015
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma. Leukemia & lymphoma	LJ Nastoupil, PJ Shenoy, A Ambinder, JL Koff, AK Nooka, EK Waller, A Langston, M Seward, JL Kaufman, L Bernal-Mizrachi, N King, MJ Lechowicz, S Lonial, R Sinha, CR Flowers	01/02/2015
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome. Bone marrow transplantation	MJ Lechowicz, HM Lazarus, J Carreras, GG Laport, CS Cutler, PH Wiernik, GA Hale, D Maharaj, RP Gale, PA Rowlings, CO Freytes, AM Miller, JM Vose, RT Maziarz, S Montoto, DG Maloney, PN Hari	01/11/2014
Breast Implant-Associated Anaplastic Large Cell Lymphoma: Report of 2 Cases and Review of the Literature. Aesthetic surgery journal	AM Hart, MJ Lechowicz, KK Peters, J Holden, GW Carlson	01/08/2014
Right ventricular myocarditis and its deceptive electrical signal. International journal of cardiology	PT Strickland, GR Hartlage, MJ Lechowicz, SD Clements	15/07/2014
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors. Bone marrow transplantation	AA Langston, JM Prichard, S Muppidi, A Nooka, MJ Lechowicz, S Lonial, R Sinha, M Graiser, JL Kaufman, HJ Khoury, CR Flowers, EK Waller	01/02/2014
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma. Clinical lymphoma, myeloma & leukemia	R Sinha, PJ Shenoy, N King, MJ Lechowicz, K Bumpers, D Hutcherson, M Arellano, A Langston, J Kaufman, LT Heffner, EK Waller, A Nooka, CR Flowers, S Lonial	01/12/2013
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	RD Harvey, JL Kaufman, HR Johnson, A Nooka, L Vaughn, CR Flowers, HJ Khoury, MJ Lechowicz, AA Langston, S Lonial, EK Waller	01/09/2013
Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leukemia & lymphoma	MH Imam, PJ Shenoy, CR Flowers, A Phillips, MJ Lechowicz	01/04/2013
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Lonial, M Akhtari, J Kaufman, C Torre, MJ Lechowicz, C Flowers, R Sinha, HJ Khoury, AA Langston, EK Waller	01/03/2013
Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leukemia & lymphoma	CR Flowers, PJ Shenoy, U Borate, K Bumpers, T Douglas-Holland, N King, OW Brawley, J Lipscomb, MJ Lechowicz, R Sinha, RS Grover, L Bernal-Mizrachi, J Kowalski, W Donnellan, A The, V Reddy, DL Jaye, J Foran	01/02/2013
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma. Transfusion	JL Kaufman, CR Flowers, KD Rados, GB Calandra, JM Vose, LB Hewes, S Lonial, AA Langston, HJ Khoury, MJ Lechowicz, EK Waller	01/01/2013
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase. British journal of haematology	D Muringampurath-John, DL Jaye, CR Flowers, D Saxe, Z Chen, MJ Lechowicz, DD Weisenburger, M Bast, ML Arellano, L Bernal-Mizrachi, LT Heffner, M McLemore, JL Kaufman, EF Winton, S Lonial, JO Armitage, HJ Khoury	01/09/2012
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas. Cancer	R Sinha, JL Kaufman, HJ Khoury, N King, PJ Shenoy, C Lewis, K Bumpers, A Hutchison-Rzepka, M Tighiouart, LT Heffner, MJ Lechowicz, S Lonial, CR Flowers	15/07/2012
Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma. Leukemia & lymphoma	D Muringampurath-John, CR Flowers, M Toscano, C Zhengjia, JL Kaufman, M Arellano, L Bernal-Mizrachi, LT Heffner, MJ Lechowicz, M McLemore, E Winton, DL Jaye, S Lonial, HJ Khoury	01/04/2012
Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's disease. Current drug delivery	E Reid, A Nooka, J Blackmon, MJ Lechowicz	01/01/2012
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion	J Li, E Hamilton, L Vaughn, M Graiser, H Renfroe, MJ Lechowicz, A Langston, JM Prichard, D Anderson, C Gleason, S Lonial, CR Flowers, JL Kaufman, EK Waller	01/10/2011
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. ISRN hematology	AN Abouyabis, PJ Shenoy, R Sinha, CR Flowers, MJ Lechowicz	01/01/2011
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion	M Akhtari, CR Giver, Z Ali, CR Flowers, CL Gleason, CD Hillyer, J Kaufman, HJ Khoury, AA Langston, MJ Lechowicz, S Lonial, HM Renfroe, JD Roback, M Tighiouart, L Vaughn, EK Waller	01/11/2010
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study. Clinical cancer research : an official journal of the American Association for Cancer Research	S Lonial, J Kaufman, M Tighiouart, A Nooka, AA Langston, LT Heffner, C Torre, S McMillan, H Renfroe, RD Harvey, MJ Lechowicz, HJ Khoury, CR Flowers, EK Waller	15/10/2010
Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits? Clinical lymphoma, myeloma & leukemia	P Shenoy, R Sinha, JW Tumeh, MJ Lechowicz, CR Flowers	01/08/2010
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leukemia & lymphoma	H Tran, M Arellano, A Chamsuddin, C Flowers, LT Heffner, A Langston, MJ Lechowicz, A Tindol, E Waller, EF Winton, HJ Khoury	01/08/2010
A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma. American journal of clinical pathology	SD Schniederjan, S Li, DF Saxe, MJ Lechowicz, KL Lee, PD Terry, KP Mann	01/05/2010
Nasal NK/T-cell lymphoma: where are we now? Oncology (Williston Park, N.Y.)	MJ Lechowicz	15/04/2010
HIV-K: an integrative knowledge base for semantic integration of AIDS-related malignancy data and treatment outcomes. Studies in health technology and informatics	A Tirado-Ramos, J Saltz, MJ Lechowicz	01/01/2010
Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America	M Lechowicz, DP Dittmer, JY Lee, SE Krown, W Wachsman, D Aboulafia, BJ Dezube, L Ratner, J Said, RF Ambinder	15/12/2009
Spectrum of FDG PET/CT findings in Burkitt lymphoma. Clinical nuclear medicine	W Zeng, MJ Lechowicz, E Winton, SM Cho, JR Galt, R Halkar	01/06/2009
Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leukemia & lymphoma	AN Abouyabis, PJ Shenoy, MJ Lechowicz, CR Flowers	01/11/2008
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma. Bone marrow transplantation	S Murali, E Winton, EK Waller, LT Heffner, S Lonial, C Flowers, J Kaufman, M Arellano, MJ Lechowicz, KP Mann, HJ Khoury, AA Langston	01/10/2008
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma. Leukemia & lymphoma	S Lonial, M Arellano, D Hutcherson, A Langston, C Flowers, LT Heffner, E Winton, M Jo Lechowicz, EK Waller	01/10/2006

Awards

Exemplary Teacher of the Year Award, Emory University, 2019
Dean's Teaching Award, Emory University School of Medicine, 2018-2019
Dean's Teaching Award, Emory University School of Medicine, 2012-2013
Emory University School of Medicine Class of 2013, Senior Superlatives Awards – Student Elected
"Doctor who could take care of your Grandmother"
Named "The Dr. Mary Jo Lechowicz Award", 2013
Emory University School of Medicine Class of 2011, Senior Superlatives Awards – Student Elected
"Doctor whom you would take your family to in medical subspecialties"
Named "The Dr. Mary Jo Lechowicz Award", 2011

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.9	One star One star One star One star One half star	Provider discussed treatment options
4.9	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	26/04/2024	Fantastic care given by my doctor.
One star One star One star One star One star	31/03/2024	Excellent
One star One star One star One star One star	29/03/2024	Dr. Lechowicz is an exceptionally caring pyhsician who gave me plenty of time to discuss my issues and she seemed to really care about how I am doing. I have great admiration for her and confidence in her.
One star One star One star One star One star	26/03/2024	DrLechewicz was very patient and listened to all my questions and spent time explaining test results and making recommendations, etc. She is a very caring, concerned Dr. For her patients.
One star One star One star One star One star	26/03/2024	Excellent. She is ALWAYS engaged, interested, thoughtful and studies the clues like no one else!! Perfect!
One star One star One star One star One star	02/03/2024	Generous with her time
One star One star One star One star One star	01/03/2024	Dr Lechowicz was as usual incredibly kind, thorough, knowledgeable and compassionate.
One star One star One star One star One star	22/02/2024	I am very pleased with Dr Lechowicz. She is empathetic, compassionate, and very involved in my care.
One star One star One star One star One star	11/02/2024	Doctor was concerned about my physical skin tone. She took the time to call my Dermatologist to get my records because her affiliation does not have MyChart. I went by the Dermatologist's office to sign a Relase so there would be no delay.
One star One star One star One star One star	07/02/2024	She's been my Doctor since 2007. I don't know what I would do without her.
One star One star One star One star One star	14/01/2024	Very good
One star One star One star One star One star	14/01/2024	Great communications
One star One star One star One star One star	12/01/2024	Dr Lechowicz is empathetic, knowledgeable, and kind.
One star One star One star One star One star	05/01/2024	Dr. Lechowicz is an excellent practitioner
One star One star One star One star One star	22/12/2023	Dr. Lechowicz is a special person, a doctor who cares.
One star One star One star One star One star	19/12/2023	Been seeing Dr. Lechowicz for 20 years now. Absolutely love her. Feel like she's a sister me. The best doctor to me!
One star One star One star One star One star	05/12/2023	Dr. Lechowicz is the best!
One star One star One star One star One star	20/11/2023	She is a fantastic doctor and person. I have told many people about Dr Lechowicz and the beyond excellent care I receive from her.
One star One star One star One star One star	25/10/2023	Good
One star One star One star One star One star	24/10/2023	Dr. Lecowicz is very compassionate, interested in her patient's situation, and sincere
One star One star One star One star One star	29/09/2023	Dr.Lechoweiz is a very caring and professional doctor. I recommend her to all friends who have cancer.
One star One star One star One star One star	27/09/2023	Good
One star One star One star One star One half star	15/09/2023	As I said, her instructions were very good, but we had limited time and felt like we needed more discussion about treatment options.
One star One star One star One star One half star	01/09/2023	The doctor was hurried yet she was still excellent. She is a keeper .
One star One star One star One star One star	29/08/2023	Only great results pertaining to Dr.Lechowitz, as stated before
One star One star One star One star One star	22/08/2023	Simply one of the best doctors, primary care, specialist, or otherwise I've ever had! She's thorough and attentive to my needs!
One star One star One star One star One star	16/08/2023	I have nothing but the highest regard for the care I've received at Emory so far!
One star One star One star One star One half star	08/08/2023	She asked many questions to get to the core problem .She gained my confidence .
One star One star One star One star One star	28/07/2023	Dr. Lechowicz is an awesome oncologist!
One star One star One star One star One star	29/06/2023	Dr. Lechowicz is a wonderful, caring doctor. She's the best.
One star One star One star One star Empty star	26/05/2023	Good
One star One star One star One star One star	22/05/2023	I recommend Dr Lechowicz highlt !!
One star One star One star One star One star	05/05/2023	Can't not say enough good things about Dr. Lechowicz. I consider myself extremely grateful to be in her care.
One star One star One star One star One star	03/05/2023	Excellent!
One star One star One star One star One star	02/05/2023	She always explains everything to me and I like that about her.
One star One star One star One star One star	01/05/2023	Dr. Lechowicz is an excellent provider and always shows additional concern and care for her patients. I would definitely recommend her to family and friends for future care.
One star One star One star One star One star	24/04/2023	Dr Lechowicz is the best expert in Winship!! She is very personal and knows how to treat cancern..
One star One star One star One star Empty star	07/03/2023	Good
One star One star One star One star One star	03/03/2023	Thoroughness of exam. Empathic listening. Knowledge of my rare lymphoma.
One star One star One star One star One star	28/02/2023	Care providers were wonderful as expected.
One star One star One star One star One star	17/02/2023	Dr. Lechowicz us a fabulous doctor. She has been keeping me going for 10 years.
One star One star One star One star One half star	16/02/2023	Dr.Lechowitz is very professional and caring two qualities that exhibit an exceptional physician!!
One star One star One star One star One star	10/02/2023	I love Mary Jo, she is truly the best Doctor and best bedside manners. She makes you feel like she really care and that she has known you for years.
One star One star One star One star One star	09/02/2023	The doctor was amazing. Her bedside manner is top notch and she shows genuine care and concern for her patients. She explains what she is going to do in reference to testing and her opinions about what is happening to you. Answered all questions and spent a good amount of time with me.
One star One star One star One star One star	02/02/2023	She was very compassionate ,and went above her job title to help me receive the adequate care.
One star One star One star One star One star	31/01/2023	I can not say enough good things about Dr. Lechowicz. Very caring, thorough and professional always.
One star One star One star One star One star	19/12/2022	Best Doctor bedside manners I've ever experienced.
One star One star One star One star One star	18/12/2022	Saved my life. Not much argument here.
One star One star One star One star One star	16/12/2022	Dr. Lechowicz is The Best!
One star One star One star One star One star	04/12/2022	The best part of my visit very thorough and patient. Answered all my questions
One star One star One star One star One star	28/10/2022	Execellent care provider, goes beyond the normal to ensure patient needs are met!! Would definitely refer them to family and friends..
One star One star One star One star One star	13/09/2022	Dr Lechowitcz is awesome! And so considerate of my time. I appreciate her so much.
One star One star One star One star One star	13/09/2022	Absolutely the best doctor anyone could hope for. Dr Lechowiz and her staff is amazing
One star One star One star One star One star	05/09/2022	Excellent physician, shows a genuine care about the patient and goes beyond the normal to ensure the individual's needs are met! I am a retired veteran who has been treated by various doctors around the world. Dr Lechowicz is definitely one of the best and truly appreciated!
One star One star One star One star One star	30/08/2022	Dr Lechowicz is very professional yet personable. She is such a huge credit to her profession and Emory as a whole.
One star One star One star One star One star	02/08/2022	I find Dr. Leuchowicz very knowledgeable and easy to discuss my issues with her. I feel privileged to have her as my doctor and will definitely recommend her.
One star One star One star One star One star	08/07/2022	Helpful and acceptable of our choices
One star One star One star One star One star	21/06/2022	Dr. Lechowicz provided excellent consultation.
One star One star One star One star One star	13/06/2022	Love my doctor!
One star One star One star One star One star	19/05/2022	She is excellent! The doctor we have been praying for-thorough, approachable, caring, honest and personable.